Skip to main content
. 2017 Jul 28;18:255. doi: 10.1186/s12882-017-0672-9

Table 1.

Baseline patient’s characteristics according to subgroup. Data are expressed as frequency and percentage or as median (IQR)

Variables Overall Equal Improved Worse p-value a
Gender 0.035
 Female 65 (19.9) 40 (17.5) 12 (19.4) 13 (36.1)
 Male 261 (80.1) 188 (82.5) 50 (80.6) 23 (63.9)
Race 0.522
 caucasian 300 (92.0) 211 (92.5) 55 (88.7) 34 (94.4)
 non caucasian 26 (8.0) 17 (7.5) 7 (11.3) 2 (5.6)
Risk factor 0.213
 homosexuals 120 (36.8) 90 (40.0) 22 (35.5) 8 (22.2)
 IV Drug user 49 (15.0) 32 (14.2) 12 (19.3) 5 (13.9)
 heterosexuals 154 (47.2) 103 (45.8) 28 (45.2) 23 (63.9)
HCV 0.488
 no 360 (79.7) 182 (79.8) 47 (75.8) 31 (86.1)
 yes 66 (20.3) 46 (20.2) 15 (24.2) 5 (13.9)
Diabetes 0.242
 no 296 (90.8) 203 (89.0) 59 (95.2) 34 (94.4)
 yes 30 (9.2) 25 (11.0) 3 (4.8) 2 (5.6)
Hypertension 0.028
 no 237 (72.7) 156 (68.4) 52 (83.9) 29 (80.6)
 yes 89 (27.3) 72 (31.6) 10 (16.1) 7 (19.4)
ART 0.415
 no 25 (7.7) 20 (8.8) 4 (6.3) 1 (2.8)
 yes 301 (92.3) 207 (92.2) 59 (93.7) 35 (97.2)
TDF based ART 0.040
 no 123 (45.4) 94 (45.4) 19 (32.2) 10 (28.6)
 yes 178 (54.6) 113 (54.6) 40 (67.8) 25 (71.4)
Type of ART 0.926
 NNRTI 146 (47.0) 101 (47.4) 29 (48.3) 16 (43.2)
 IP 120 (38.8) 81 (38.0) 24 (40.0) 15 (40.5)
 INI 44 (14.2) 31 (14.6) 7 (11.7) 6 (16.3)
AIDS 0.544
 no 247 (75.8) 169 (74.1) 50 (80.6) 28 (77.8)
 yes 79 (24.2) 59 (25.9) 12 (19.4) 8 (22.2)
Smoke 0.609
 no 153 (46.9) 108 (47.4) 28 (45.2) 17 (47.2)
 yes 130 (39.9) 88 (38.6) 29 (46.8) 13 (36.1)
 ex 43 (13.2) 32 (14.0) 5 (8.0) 6 (16.7)
BMI 24.8 (22.3–28.0) 24.6 (22.1-27.7) 26.0 (23.6-30.1) 24.1 (22.5-26.7) 0.024 b
Duration of disease 10.0 (5.0-17.0) 11.0 (6.0-17.7) 11.0 (4.0-17.0) 7.0 (5.0-15.7) 0.302b

aChi-squared test; bStudent t-test for unpaired data. P values in bold suggest significant values.